Japan’s No.1 in cardiovascular sales
We have the largest market share in the products for PCI (percutaneous coronary intervention), minimally invasive treatments for myocardial infarction and angina pectoris in Japan.
*(Source) WIN Partners
WIN-Partners group aims for higher growth, by expanding sales network and customer base as well as expanding treatment areas and products.
We are successfully expanding sales network based on our speciality in mininally invasive treatment fields and proposals in light of hospital management.